1 The retractions came only months after BioMed Central.

An editor at among the journals released by Sage Publications became suspicious, sparking a lengthy and comprehensive investigation, in July 2014 which resulted in the retraction of 60 articles. By the end of 2014, BioMed Central and other publishers alerted the international Committee on Publication...
Continue reading »

Announced today a collaboration contract with Eisai Inc.

Aestus, Eisai collaborate to research and develop novel therapeutics for psychiatric disorders Aestus Therapeutics, Inc http://cialissverige.org . announced today a collaboration contract with Eisai Inc. on research and advancement of novel therapeutics for the treatment of psychiatric disorders. The multi-season collaboration will entail pre-medical validation...
Continue reading »

According to a new research in Gastroenterology.

Incidence of the disease, which causes intestinal irritation, is on the rise in children. This research is the largest double-blind research of an anti-TNF agent in kids with Crohn’s disease. By six months, approximately 34 % of patients were in clinical remission, and after a...
Continue reading »

A central health laws question: Who is getting covered?

Infrequent reports of significant blood disorders have been reported with TNF-blocking agents. More situations of malignancies have been observed among patients receiving TNF blockers, including HUMIRA, compared to control patients in scientific trials. These malignancies, apart from lymphoma and non-melanoma pores and skin cancer, were...
Continue reading »

Lisa Rosenbaum.

Doctors retiring early. Small practices bankrupted by up-front expenses or locked into ineffective systems by the prohibitive price of switching. Hours consumed by onerous data access unrelated to patient treatment. Workflow disruptions. And above all, substantial intrusions on our affected person relationships. These complaints could...
Continue reading »

In case you are.

Tony Mok, M.D., professor, Division of Clinical Oncology, The Chinese University of Hong Kong, and senior investigator of the Phase 1b/2 trial commented, The Phase 1b data present that the combination of ficlatuzumab and gefinitib demonstrated promising medical activity and was well tolerated in patients....
Continue reading »

Alaska is 20th state to become listed on health reform lawsuit.

Consider signing on Alaska Republican Gov. Sean Parnell has said he will make Alaska the 20th condition to join a lawsuit complicated the constitutionality of the new health reform legislation, The Anchorage Daily Information/McClatchy record. ‘The Constitution gives Congress the authority to modify interstate commerce....
Continue reading »

AMRI receives $750.

To date, Bristol-Myers Squibb has chosen two compounds out of this program for acceptance to initiate Phase I studies. The two companies will continue to evaluate additional substances under this collaboration to build up improved treatments for diseases of the central anxious system . Per...
Continue reading »

Changpin Zhang.

Robert F. Pass, M impotencia .D., Changpin Zhang, M.D., Ashley Evans, M.D., Tina Simpson, M.D., William Andrews, M.D., Meei-Li Huang, Ph.D., Lawrence Corey, M.D., Janie Hill, R.N., Elizabeth Davis, R.N., M.P.H., Cynthia Flanigan, B.S., and Gretchen Cloud, M.S.: Vaccine Prevention of Maternal Cytomegalovirus Infection Congenital...
Continue reading »

Darrell Crawford.

The scholarly study was conducted in accordance with the International Conference on Harmonisation guidelines, applicable rules, and the principles of the Declaration of Helsinki. The analysis protocol was accepted by the independent ethics committee or institutional review board at each study site. The analysis was...
Continue reading »

Results will be published in the Aug.

The standard lifetime risk to develop Parkinson’s disease for men and women combined is certainly 1.7 %.. Allergic rhinitis from the development of Parkinson’s disease Researchers from Mayo Clinic can see that allergic rhinitis is linked to the development of Parkinson’s disease later in lifestyle....
Continue reading »